← Russell 3000 cross-section

EHC Encompass Health Corp

Trailing twelve months to 2026-06-30 · as filed 2026-08-07, not restated
Healthcare

Scale

Market cap
$11.8bn
Revenue TTM
$6.2bn
Net income TTM
$621m
Free cash flow
$413m
Composite score
Sector rank
#644

Valuation

P / E
19.0
EV / EBITDA
EV / sales
1.9
FCF yield
3.51%
Earnings yield vs 10-yr
0.54pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
10.0%
EBITDA margin
ROE
23.9%
ROIC
Revenue growth
9.5%

Insider activity, last 90 days

Net open-market
$-25.21m
Buyers
0
Sellers
3

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

The terms of the 2026 Credit Agreement are substantially the same as the terms of the 2022 Credit Agreement, except that (i) the maturity date has been changed to March 9, 2031, (ii) the fee for the undrawn portion of the revolving loan commitment has been lowered by five basis points, (iii) certain limitations on the ability of us and our subsidiaries to make investments, incur debt or liens, or make restricted payments have been relaxed, (iv) the 0.10 % adjustment to interest payable on Term SOFR Borrowings has been eliminated, and (v) the swingline loan sublimit has been increased from $ 25 million to $ 40 million. …Encompass Health Corp, 10-Q, period ended 2026-06-30, filed 2026-08-07

Read the full passage →